Bactiguard Holding AB (publ) (BACTI-B.ST)
BACTI-B.ST Stock Price Chart
Explore Bactiguard Holding AB (publ) interactive price chart. Choose custom timeframes to analyze BACTI-B.ST price movements and trends.
BACTI-B.ST Company Profile
Discover essential business fundamentals and corporate details for Bactiguard Holding AB (publ) (BACTI-B.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
19 Jun 2014
Employees
147.00
Website
https://www.bactiguard.comCEO
Christine Lind
Description
Bactiguard Holding AB (publ), a medical device company, engages in the development and supply of infection prevention solutions in Sweden and internationally. Its infection prevention solutions reduce the risk of healthcare associated infections and the use of antibiotics. The company's products portfolio of urinary catheters, endotracheal tubes, and central venous catheters reduces the risk of infections in the urinary tract, the respiratory tract, and the bloodstream. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter and BIP Endotracheal Tube, which reduces the risk of biofilm formation and infection; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention. The company's products also include Bactiguard Wound Care and Hydrocyn aqua advanced wound care, a wound wash, debridement, and irrigation solution for acute, chronic, and infected wounds; surgical sutures comprise non-absorbable, natural absorbable, synthetic absorbable, and specialty sutures; VigiMesh, a sterile, non-absorbable, and knitted polypropylene monofilament mesh material for tissue reinforcement used in hernia repair; and Hydrocyn aqua advanced disinfectant, a non-alcoholic disinfectant for skin and surfaces to kill bacteria, virus, and fungi. In addition, it offers ZNN Bactiguard, an orthopedic trauma implants with infection prevention technology; and Aniocyn, a wound and skin care products for dogs, cats, horses, and other pets. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Tullinge, Sweden.
BACTI-B.ST Financial Timeline
Browse a chronological timeline of Bactiguard Holding AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Apr 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 23 Oct 2025
Earnings released on 15 Jul 2025
EPS came in at -kr 0.23 surpassing the estimated -kr 0.26 by +10.97%, while revenue for the quarter reached kr 48.24M , missing expectations by -26.90%.
Earnings released on 24 Apr 2025
EPS came in at -kr 0.13 surpassing the estimated -kr 0.27 by +50.03%, while revenue for the quarter reached kr 59.05M , missing expectations by -10.53%.
Earnings released on 6 Feb 2025
EPS came in at -kr 0.03 surpassing the estimated -kr 0.35 by +92.50%, while revenue for the quarter reached kr 68.26M , beating expectations by +13.76%.
Earnings released on 24 Oct 2024
EPS came in at -kr 0.13 surpassing the estimated -kr 0.44 by +69.69%, while revenue for the quarter reached kr 73.94M , beating expectations by +44.97%.
Earnings released on 16 Jul 2024
EPS came in at -kr 0.41 surpassing the estimated -kr 0.60 by +31.91%, while revenue for the quarter reached kr 57.35M , beating expectations by +17.05%.
Earnings released on 25 Apr 2024
EPS came in at -kr 0.28 surpassing the estimated -kr 0.67 by +57.83%, while revenue for the quarter reached kr 53.93M , beating expectations by +12.35%.
Earnings released on 8 Feb 2024
EPS came in at -kr 0.78 surpassing the estimated -kr 0.84 by +7.54%, while revenue for the quarter reached kr 56.25M , beating expectations by +12.50%.
Earnings released on 27 Oct 2023
EPS came in at -kr 0.70 , while revenue for the quarter reached kr 49.49M .
Earnings released on 7 Jul 2023
EPS came in at -kr 1.84 , while revenue for the quarter reached kr 51.19M .
Earnings released on 27 Apr 2023
EPS came in at -kr 0.63 , while revenue for the quarter reached kr 61.16M .
Earnings released on 9 Feb 2023
EPS came in at -kr 0.40 , while revenue for the quarter reached kr 42.24M .
Earnings released on 27 Oct 2022
EPS came in at -kr 0.24 , while revenue for the quarter reached kr 66.19M .
Earnings released on 14 Jul 2022
EPS came in at -kr 0.39 , while revenue for the quarter reached kr 59.93M .
Earnings released on 27 Apr 2022
EPS came in at -kr 0.47 , while revenue for the quarter reached kr 55.20M .
Earnings released on 9 Feb 2022
EPS came in at -kr 0.72 , while revenue for the quarter reached kr 36.49M .
Earnings released on 28 Oct 2021
EPS came in at -kr 0.31 , while revenue for the quarter reached kr 45.20M .
Earnings released on 15 Jul 2021
EPS came in at -kr 0.36 , while revenue for the quarter reached kr 46.02M .
Earnings released on 22 Apr 2021
EPS came in at -kr 0.31 , while revenue for the quarter reached kr 41.78M .
Earnings released on 4 Feb 2021
EPS came in at -kr 0.32 , while revenue for the quarter reached kr 41.85M .
Earnings released on 5 Nov 2020
EPS came in at -kr 0.48 , while revenue for the quarter reached kr 34.15M .
BACTI-B.ST Stock Performance
Access detailed BACTI-B.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.